Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Cell Biochem Funct ; 20(1): 47-59, 2002 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-11835270

RESUMO

Mitochondrial, endoplasmic reticular and plasma membrane fractions were isolated by a new method from control male Fischer 344 rats and rats given CCl4 by gavage. After 1 h of CCl4 treatment, rats were in glucose and pancreatic hormone balance but plasma levels of T3 and T4 were decreased 29 and 22%, respectively. After 24 hours of CCl4 treatment, rats were: hypoglycaemic and insulin and glucagon levels were increased 33- and 35-fold, respectively; total T4 levels were decreased 62%; while total T3 levels were normalized. In liver fractions from CCl4-treated rats, 1 h after CCl4 administration: (i) calcium binding was decreased 65% in the mitochondrial fraction, 66% in the endoplasmic reticular fraction and 46% in the plasma membrane fraction; (ii) calcium uptake was decreased 59% in the mitochondrial fraction, 46% in the endoplasmic reticular fraction and 37% in the plasma membrane fraction. After 24 h of CCl4 administration: (i) calcium binding was decreased 57% in the mitochondrial fraction, 50% in the endoplasmic reticular fraction and 71% in the plasma membrane fraction; (ii). calcium uptake was decreased 55% in the mitochondrial fraction, 17% in the endoplasmic reticular fraction and 53% in the plasma membrane fraction. In vitro studies indicated the plasma membrane calcium transport system to be rapidly (within a minute) and strongly (>90%) inhibited by CCl4. We conclude that CCl4 produces a differential inhibitory effect on the hepatocyte calcium pumps that are implicated with hepatocellular damage.


Assuntos
Bloqueadores dos Canais de Cálcio/farmacologia , Tetracloreto de Carbono/farmacologia , Retículo Endoplasmático/efeitos dos fármacos , Fígado/metabolismo , Mitocôndrias Hepáticas/efeitos dos fármacos , Animais , Transporte Biológico Ativo , Glicemia/análise , Cálcio/metabolismo , Tetracloreto de Carbono/metabolismo , Tetracloreto de Carbono/toxicidade , Membrana Celular/efeitos dos fármacos , Membrana Celular/metabolismo , Relação Dose-Resposta a Droga , Retículo Endoplasmático/metabolismo , Glucagon/sangue , Hepatócitos/efeitos dos fármacos , Hepatócitos/metabolismo , Hipoglicemia/induzido quimicamente , Insulina/sangue , Membranas Intracelulares/efeitos dos fármacos , Membranas Intracelulares/metabolismo , Fígado/efeitos dos fármacos , Masculino , Mitocôndrias Hepáticas/metabolismo , Ratos , Ratos Endogâmicos F344 , Tiroxina/sangue , Fatores de Tempo , Tri-Iodotironina/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...